These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 12820632

  • 1. Inhalant abuse treatment and prevention.
    Public Health Rep; 2003; 118(3):276. PubMed ID: 12820632
    [No Abstract] [Full Text] [Related]

  • 2. SAMHSA releases revised and updated treatment improvement protocol on co-occurring disorders.
    Psychiatr Serv; 2005 Mar; 56(3):371. PubMed ID: 15816109
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Linking research and service delivery: the unique mission of the Substance Abuse and Mental Health Services Administration.
    Jansen MA.
    NIDA Res Monogr; 1994 Mar; 140():23-6. PubMed ID: 8722449
    [No Abstract] [Full Text] [Related]

  • 5. Huffing: prehospital identification & treatment of inhalant abuse.
    Criss L.
    JEMS; 2009 May; 34(5):42-3, 45, 47 passim. PubMed ID: 19433235
    [Abstract] [Full Text] [Related]

  • 6. Evaluating drug abuse treatment: a comment on the state of the art.
    Jaffe JH.
    NIDA Res Monogr; 1984 May; 51():13-28. PubMed ID: 6095081
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhalant abuse.
    Williams JF, Storck M, American Academy of Pediatrics Committee on Substance Abuse, American Academy of Pediatrics Committee on Native American Child Health.
    Pediatrics; 2007 May; 119(5):1009-17. PubMed ID: 17473104
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhalant use and abuse in Canada.
    Smart RG.
    NIDA Res Monogr; 1988 May; 85():121-39. PubMed ID: 3145435
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM, Raskin IE, Blacklow B.
    Subst Use Misuse; 2008 May; 43(5):647-79. PubMed ID: 18393082
    [Abstract] [Full Text] [Related]

  • 15. Disparities in young adolescent inhalant use by rurality, gender, and ethnicity.
    Edwards RW, Stanley L, Plested BA, Marquart BS, Chen J, Thurman PJ.
    Subst Use Misuse; 2007 May; 42(4):643-70. PubMed ID: 17558955
    [Abstract] [Full Text] [Related]

  • 16. Inhalant abuse.
    Espeland K.
    Lippincotts Prim Care Pract; 2000 May; 4(3):336-40. PubMed ID: 11271129
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The CSAT methamphetamine treatment project: what are we trying to accomplish?
    Anglin MD, Rawson RA.
    J Psychoactive Drugs; 2000 May; 32(2):209-10. PubMed ID: 10908009
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.